Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Auris Medical reports results from extension study of AM-101 for tinnitus

May 10, 2017

Auris Medical reports results from Keyzilen extension study AMPACT2 in acute inner ear tinnitus

April 25, 2017

AAV8-whirlin restores balance and auditory function in preclinical model of Usher syndrome

April 19, 2017

Spiral signs option agreement with Bionure for SGK agonists for inner ear disorders

March 31, 2017

FDA grants fast track designation to Auris Medical's AM-111

Feb. 27, 2017

Auris Medical extends collaboration with King's College London

Feb. 23, 2017

European Commission awards orphan drug designation to SENS-401

Nov. 28, 2016

Sensorion reports results from phase I study of SENS-218 for inner ear lesions

Sep. 8, 2016

Auris Medical's phase III trial of Keylizen does not meet its two coprimary efficacy endpoints

Aug. 19, 2016

FDA's clinical hold on CGF-166 lifted

July 26, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...